Important note: Information in this article was accurate in 2008. The state of the art may have changed since the publication date.
South African Press Association - June 13, 2008
In a ruling handed down on Friday morning, Judge Dumasini Zondi barred Rath from claiming his product, VitaCell, was a treatment for Aids, and declared that the clinical trials he had been conducting in black townships were unlawful.
Zondi also said Health Minister Manto Tshabalala-Msimang and her department had a duty to investigate Rath's activities.
"This judgement this morning [Friday] is a victory for the rule of law and the scientific governance of medicine," TAC spokesperson Nathan Geffen told journalists at a media briefing soon afterwards.
"Over the last decade in this country that rule of law has been contested by our minister of health and the president, and a culture of impunity has been created such that charlatans like Matthias Rath can get away with deceiving vulnerable people into taking snake oils such that those people end up progressing to Aids and dying."
Geffen said the TAC was aware of at least 12 people who had died of Aids after going to Rath's clinics and not seeking appropriate treatment at public health clinics.
"So although this is a great victory today, let's not forget that there were real human lives lost as a consequence of the actions of Matthias Rath and, more importantly, by the failure of Manto Tshabalala-Msimang and the president to stop this sort of quackery."
Geffen said there were quacks and charlatans everywhere in the world.
What made South Africa different was that here they had political support of the health minister and ultimately the President, Thabo Mbeki.
It was this that allowed them to act with impunity and be so pervasive.
In his ruling, Judge Zondi declared that the clinical trials conducted in South Africa by or under the direction of Rath and his Dr Rath Foundation were "unlawful", and interdicted them from conducting any further trials.
He also ordered that Rath not publish advertisements touting the supposed anti-aids benefits of his VitaCell until he had submitted the product to the Medicines Control Council.
Zondi said the minister and her director general -- who both opposed the TAC court application -- had a duty to take "reasonable measures" to prevent Rath from conducting trials and from advertising VitaCell.
The judge said they should investigate the trials that have taken place, and the VitaCell adverts, "and in the light of the facts revealed by such investigation, to take further reasonable action in accordance with their duty".
Zondi ordered Rath and the foundation to pay 90% of the TAC's costs, and the minister and the director general to pay the rest.
080613
SA080601
Copyright © 2008 - South African Press Association. Reproduction of this article (other than one copy for personal reference) must be cleared through the South African Press Association, Cotswold House, Greenacres Office Park, Cnr. Victory & Rustenburg Roads, VICTORY PARK, PO BOX 7766, JOHANNESBURG, 2000; Fax No: +27 11 782-1587/8, Tel No: +27 11 782-1600.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.
Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .